NEW YORK (GenomeWeb News) — Bruker BioSciences today said it has obtained a non-exclusive worldwide license from Health Discovery Corporation to use its Support Vector Machine (SVM) technology in Bruker Daltonics’ ClinProTools clinical proteomics product line.
 
ClinProTools is a bioinformatics product for biomarker panel analysis, biofluid profiling, multivariate data analysis, classical statistics, and sample classification.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.